[Participation indicators of organized cervical cancer screening in Hungary].

Q4 Medicine Magyar onkologia Pub Date : 2022-10-05 Epub Date: 2022-08-31
Réka Vajda, József Bódis, Dalma Pónusz-Kovács, Diána Elmer, Fanni Luca Kajos, Tímea Csákvári, Zsuzsanna Kívés, Imre Boncz
{"title":"[Participation indicators of organized cervical cancer screening in Hungary].","authors":"Réka Vajda,&nbsp;József Bódis,&nbsp;Dalma Pónusz-Kovács,&nbsp;Diána Elmer,&nbsp;Fanni Luca Kajos,&nbsp;Tímea Csákvári,&nbsp;Zsuzsanna Kívés,&nbsp;Imre Boncz","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to determine the percentage of women in Hungary who underwent gynecological cytological examinations either as part of a screening test or diagnostic examinations. Data derived from the nationwide financing database of the Hungarian National Health Insurance Fund Management and covered the period 2008-2021. We analyzed both diagnostic and screening cytological tests. The number of diagnostic tests has decreased. The number of patients per 10,000 female inhabitants in 2021 was a national average of 840. The highest rate was observed in the counties of Hajdú-Bihar (1464/10,000 female inhabitants), Tolna (1443) and Baranya (1254). In screening, the number of cytological tests is lower compared to smearing. The annual participation rate decreased from 28% to 17%. The number of patients and the participation rate of diagnostic cytology examinations decreased during the examined period. The added value of screening cytology is moderate, the willingness to participate is low, falling short of the expected value.</p>","PeriodicalId":18175,"journal":{"name":"Magyar onkologia","volume":"66 3","pages":"186-193"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magyar onkologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/31 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this study was to determine the percentage of women in Hungary who underwent gynecological cytological examinations either as part of a screening test or diagnostic examinations. Data derived from the nationwide financing database of the Hungarian National Health Insurance Fund Management and covered the period 2008-2021. We analyzed both diagnostic and screening cytological tests. The number of diagnostic tests has decreased. The number of patients per 10,000 female inhabitants in 2021 was a national average of 840. The highest rate was observed in the counties of Hajdú-Bihar (1464/10,000 female inhabitants), Tolna (1443) and Baranya (1254). In screening, the number of cytological tests is lower compared to smearing. The annual participation rate decreased from 28% to 17%. The number of patients and the participation rate of diagnostic cytology examinations decreased during the examined period. The added value of screening cytology is moderate, the willingness to participate is low, falling short of the expected value.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[匈牙利有组织宫颈癌筛查的参与指标]。
这项研究的目的是确定匈牙利妇女接受妇科细胞学检查作为筛查试验或诊断检查的一部分的百分比。数据来自匈牙利国家健康保险基金管理公司的全国筹资数据库,涵盖2008-2021年期间。我们分析了诊断和筛选细胞学检查。诊断测试的数量减少了。2021年,每1万名女性居民的患者数量为全国平均水平840人。发病率最高的县为Hajdú-Bihar(1464/ 10000名女性居民)、Tolna(1443 / 10000名)和Baranya(1254 / 10000名)。在筛查中,细胞学检查的次数比涂片检查少。年参与率从28%下降到17%。在检查期间,诊断细胞学检查的患者人数和参与率下降。筛查细胞学附加值一般,参与意愿较低,未达到期望值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Magyar onkologia
Magyar onkologia Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
30
期刊最新文献
[The expanding possibilities of immuno-oncology treatments]. [Therapeutic drug monitoring for supporting oncological treatments: a new era begins]. [The role of classic serum tumor markers in the diagnosis and treatment monitoring of solid tumors in adults]. [Current therapeutic and familial implications of the genetic background of prostate cancer]. [Paraneoplastic endocrine syndromes: clinical picture and laboratory diagnostics].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1